MPO and acute coronary syndrome: On the other hand, the acute coronary syndrome was strongly linked to malondialdehyde low-density lipoprotein (MDA-LDL) as a sensitive biomarker of plaque destabilization (46) and with myeloperoxidase (MPO) that, in high concentrations, also contribute to plaque destabilization.